World Health Assembly Opens Annual Meeting in Geneva
The Seventy-ninth World Health Assembly opened in Geneva on 18 May 2026. Delegates from WHO member states will meet through 23 May to set policy and review the budget.
kff.orgThe Seventy-ninth World Health Assembly opened on 18 May 2026 in Geneva, Switzerland. The annual gathering runs through 23 May at the Palais des Nations. Delegations from all WHO member states are attending. Sessions will address the organization's policies, financial oversight, and proposed programme budget.
Proceedings are being webcast live.
Simultaneous interpretation is available in Arabic, Chinese, English, French, Russian, and Spanish. Strategic Roundtables will bring together delegates, partner agencies, civil society representatives, and experts to discuss global public health priorities.
Background The World Health Assembly serves as the decision-making body of the World Health Organization. It appoints the Director-General, supervises financial policies, and approves the programme budget each year.
Key Facts
Story Timeline
2 events- 18 May 2026
Seventy-ninth World Health Assembly opened in Geneva.
1 source@WHO - 18-23 May 2026
Sessions scheduled with live webcasts and interpretation.
1 source@WHO
Potential Impact
- 01
Decisions made this week will guide WHO policies for the coming year.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.